RS
LKFT

R Squared’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

R Squared’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-930
Closed -$25.6K – 763
2024
Q4 		$25.6K Buy
+930
New +$25.9K 0.02% 772

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

R Squared's LKFT Position: Q1 2025 in Review

R Squared sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2025, closing a stake of 930 shares — an estimated $25.6K sold.

R Squared first reported a position in LKFT in Q4 2024 and held it in 1 quarter. The position peaked at $25.6K in Q4 2024. 83 funds tracked by Wall St. Rank hold LKFT as of Q1 2025.

  • R Squared reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 930 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2025, an estimated $25.6K.
  • R Squared first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2024 and held it in 1 quarter.
  • R Squared's Lakefront Biotherapeutics American Depositary Shares position peaked at $25.6K in Q4 2024.
  • 83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.